AgeX Therapeutics Q3 EPS $(0.14) Down From $(0.06) YoY, Sales $67.00K Up From $9.00K YoY
AgeX Therapeutics Q3 EPS $(0.14) Down From $(0.06) YoY, Sales $67.00K Up From $9.00K YoY
Agex Therapeutics第三季度每股收益爲0.14美元，低於同比的0.06美元，銷售額從同比的900萬美元增長6.7萬美元
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.14) per share. This is a 133.33 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $67.00 thousand in sales this quarter. This is a 644.44 percent increase over sales of $9.00 thousand the same period last year.
Agex Therapeutics（AMEX: AGE）公佈季度每股虧損0.14美元。這比去年同期每股虧損美元（0.06）下降了133.33％。該公司報告本季度銷售額爲67,000美元。這比去年同期的9,000美元的銷售額增長了644.44％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。